Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa, Single-Arm, Open Study of Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma

NCT02848794 is registered in ClinicalTrials.gov with The First People's Hospital of Lianyungang as lead sponsor.

NCT NCT02848794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02848794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa, Single-Arm, Open Study of Apatinib and Irinotecan in Treating Patients With Recurrent High-grade Glioma
Lead sponsor
The First People's Hospital of Lianyungang
Phase
Phase 1/2
Overall status
Unknown status
Start date
July 31, 2016
Completion date
July 31, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade glioma